ES8601992A1 - Procedimiento para preparar 2-fenil-imidazoles - Google Patents

Procedimiento para preparar 2-fenil-imidazoles

Info

Publication number
ES8601992A1
ES8601992A1 ES537992A ES537992A ES8601992A1 ES 8601992 A1 ES8601992 A1 ES 8601992A1 ES 537992 A ES537992 A ES 537992A ES 537992 A ES537992 A ES 537992A ES 8601992 A1 ES8601992 A1 ES 8601992A1
Authority
ES
Spain
Prior art keywords
formula
imidazoles
phenyl
procedure
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537992A
Other languages
English (en)
Other versions
ES537992A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES8601992A1 publication Critical patent/ES8601992A1/es
Publication of ES537992A0 publication Critical patent/ES537992A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 2-FENIL-IMIDAZOLES Y DE SUS TAUTOMEROS Y SALES DE ADICION DE ACIDOS, DE FORMULA (I), EN LA QUE A, B, C, D, R1, R2 Y R3 PUEDEN SER VARIOS TIPOS DE RADICALES.CONSISTE EN LA REACCION DE CICLIZACION DE UN COMPUESTO, QUE PUEDE SER PREPARADO EN LA MEZCLA DE REACCION, DE FORMULA (II), EN LA QUE UNO DE X E Y REPRESENTA UN ATOMOD E HALOGENO Y EL OTRO PUEDE SER UNO DE VARIOS TIPOS DE RADICALES, Y A, B, C Y D TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE EFECTUA EN UN DISOLVENTE, EN PRESENCIA DE UN AGENTE ACILANTE, AGENTE CONDENSANTE O DE UNA BASE, A LA TEMPERATURA DE EBULLICION DE LA MEZCLA.ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE INSUFICIENCIAS CARDIACAS.
ES537992A 1983-12-28 1984-11-27 Procedimiento para preparar 2-fenil-imidazoles Granted ES537992A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833347290 DE3347290A1 (de) 1983-12-28 1983-12-28 Neue 2-phenyl-imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES8601992A1 true ES8601992A1 (es) 1985-11-01
ES537992A0 ES537992A0 (es) 1985-11-01

Family

ID=6218292

Family Applications (6)

Application Number Title Priority Date Filing Date
ES537992A Granted ES537992A0 (es) 1983-12-28 1984-11-27 Procedimiento para preparar 2-fenil-imidazoles
ES543086A Granted ES543086A0 (es) 1983-12-28 1985-05-13 Procedimiento para preparar nuevos 2-fenil-imidazoles
ES543084A Expired ES8603883A1 (es) 1983-12-28 1985-05-13 Procedimiento para preparar nuevos 2-fenil-imidazoles
ES543083A Granted ES543083A0 (es) 1983-12-28 1985-05-13 Procedimiento para preparar nuevos 2-fenil-imidazoles
ES543082A Granted ES543082A0 (es) 1983-12-28 1985-05-13 Procedimiento para preparar nuevos 2-fenil-imidazoles
ES543085A Granted ES543085A0 (es) 1983-12-28 1985-05-13 Procedimiento para preparar nuevos 2-fenil-imidazoles.

Family Applications After (5)

Application Number Title Priority Date Filing Date
ES543086A Granted ES543086A0 (es) 1983-12-28 1985-05-13 Procedimiento para preparar nuevos 2-fenil-imidazoles
ES543084A Expired ES8603883A1 (es) 1983-12-28 1985-05-13 Procedimiento para preparar nuevos 2-fenil-imidazoles
ES543083A Granted ES543083A0 (es) 1983-12-28 1985-05-13 Procedimiento para preparar nuevos 2-fenil-imidazoles
ES543082A Granted ES543082A0 (es) 1983-12-28 1985-05-13 Procedimiento para preparar nuevos 2-fenil-imidazoles
ES543085A Granted ES543085A0 (es) 1983-12-28 1985-05-13 Procedimiento para preparar nuevos 2-fenil-imidazoles.

Country Status (16)

Country Link
US (1) US4722929A (es)
EP (1) EP0149200A1 (es)
JP (1) JPS60172980A (es)
KR (1) KR850004476A (es)
AU (1) AU3721184A (es)
DD (1) DD231355A5 (es)
DE (1) DE3347290A1 (es)
DK (1) DK610284A (es)
ES (6) ES537992A0 (es)
FI (1) FI845117A7 (es)
GR (1) GR82597B (es)
HU (1) HUT37618A (es)
IL (1) IL73951A0 (es)
NO (1) NO845252L (es)
PT (1) PT79755B (es)
ZA (1) ZA8410057B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3217583A1 (de) * 1982-05-11 1983-11-17 Merck Patent Gmbh, 6100 Darmstadt 2-aryl-tetraazaindene
DE3346640A1 (de) * 1983-12-23 1985-07-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, deren herstellung und diese verbindungen enthaltende arzneimittel
DE3446812A1 (de) * 1984-12-21 1986-06-26 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5332744A (en) * 1989-05-30 1994-07-26 Merck & Co., Inc. Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
US5223499A (en) * 1989-05-30 1993-06-29 Merck & Co., Inc. 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
JPH06107661A (ja) * 1991-10-24 1994-04-19 Upjohn Co:The イミダゾール誘導体およびこれを有効成分とする医薬組成物
US5442062A (en) * 1991-10-24 1995-08-15 The Upjohn Company Imidazole derivatives and pharmaceutical compositions containing the same
NZ262797A (en) * 1993-02-26 1997-08-22 Schering Corp Polycyclic guanine derivatives, purine and pyrimidine precursors; medicaments
US5646156A (en) * 1994-04-25 1997-07-08 Merck & Co., Inc. Inhibition of eosinophil activation through A3 adenosine receptor antagonism
AU4501199A (en) * 1998-06-03 1999-12-20 Almirall Prodesfarma S.A. 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
GB9914825D0 (en) * 1999-06-24 1999-08-25 Smithkline Beecham Spa Novel compounds
ES2166270B1 (es) * 1999-07-27 2003-04-01 Almirall Prodesfarma Sa Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.
US6887690B2 (en) * 2001-06-22 2005-05-03 Pe Corporation Dye-labeled ribonucleotide triphosphates
AU2003220401A1 (en) * 2002-03-18 2003-10-08 Bristol-Myers Squibb Company Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
SE0301446D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab New Compounds
JP4127204B2 (ja) * 2003-12-17 2008-07-30 セイコーエプソン株式会社 液晶表示装置の製造方法
UY30048A1 (es) * 2005-12-23 2007-07-31 Astrazeneca Ab Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
TWI433839B (zh) 2006-08-11 2014-04-11 Neomed Inst 新穎的苯并咪唑衍生物290
EP2246335A1 (de) * 2009-02-17 2010-11-03 Bayer CropScience AG Aminopyrimidinamide als Schädlingsbekämpfungsmittel
CN115124534B (zh) * 2021-11-23 2023-09-15 中山大学 非核苷酸类prmt5小分子抑制剂、制备方法及用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1186504A (en) * 1966-10-15 1970-04-02 Fisons Pest Control Ltd Substituted Heterocyclic Compounds
DE2305339C3 (de) * 1973-02-03 1980-05-08 Dr. Karl Thomae Gmbh, 7950 Biberach Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
US3985891A (en) * 1973-02-03 1976-10-12 Boehringer Ingelheim Gmbh 2-Phenyl-imidazo (4,5-b)pyridines and salts thereof
DE2927987A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 2-alkoxyphenyl-imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine, deren herstellung und deren verwendung als arzneimittel
DE3037464A1 (de) * 1980-10-03 1982-05-19 Dr. Karl Thomae Gmbh, 7950 Biberach 6-hydroxy-2-phenyl-imidazo 4,5-b zu pyridine, ihre herstellung und diese sie enthaltende arzneimittel
DE3108027A1 (de) * 1981-03-03 1982-09-16 Dr. Karl Thomae Gmbh, 7950 Biberach Mittel zur behandlung von koronaren herzerkrankungen
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
US4452788A (en) * 1982-04-21 1984-06-05 Warner-Lambert Company Substituted 8-phenylxanthines
ZA832938B (en) * 1982-05-03 1984-12-24 Lilly Co Eli 2-phenylimidazo(4,5-c)pyridines
DE3217583A1 (de) * 1982-05-11 1983-11-17 Merck Patent Gmbh, 6100 Darmstadt 2-aryl-tetraazaindene
DE3346602A1 (de) * 1983-12-23 1985-07-11 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazo(4,5-c)pyridin-one, deren herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
GR82597B (en) 1985-04-29
PT79755A (de) 1985-01-01
DD231355A5 (de) 1985-12-24
DK610284D0 (da) 1984-12-19
AU3721184A (en) 1985-07-04
EP0149200A1 (de) 1985-07-24
ES8603882A1 (es) 1986-01-01
DK610284A (da) 1985-06-29
HUT37618A (en) 1986-01-23
ES543083A0 (es) 1986-01-01
NO845252L (no) 1985-07-01
ES8603881A1 (es) 1986-01-01
PT79755B (de) 1986-12-10
ZA8410057B (en) 1986-09-24
IL73951A0 (en) 1985-03-31
DE3347290A1 (de) 1985-07-11
ES543084A0 (es) 1986-01-01
ES8603883A1 (es) 1986-01-01
ES8603885A1 (es) 1986-01-01
ES543082A0 (es) 1986-01-01
ES537992A0 (es) 1985-11-01
ES8603884A1 (es) 1986-01-01
FI845117A0 (fi) 1984-12-27
US4722929A (en) 1988-02-02
JPS60172980A (ja) 1985-09-06
KR850004476A (ko) 1985-07-15
ES543086A0 (es) 1986-01-01
ES543085A0 (es) 1986-01-01
FI845117L (fi) 1985-06-29
FI845117A7 (fi) 1985-06-29

Similar Documents

Publication Publication Date Title
ES8304095A1 (es) Un procedimiento para la preparacion de derivados de quinazolina.
ES8608874A1 (es) Un procedimiento para la preparacion de una 2-(1h)-quinolona
ES8401970A1 (es) Un procedimiento para la preparacion de derivados de benzoisotiazol y benzoisoxazol piperazina.
ES8205789A1 (es) Un procedimiento para la preparacion de derivados del indol
ES8605791A1 (es) Un procedimiento para la preparacion de derivados de imida- zodiacepina
ES8704924A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
ES2039369T3 (es) Un procedimiento para la produccion de nuevos derivados de acido picolinico.
ES8706165A1 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida.
ES2189251T3 (es) Procedimiento de preparacion de diarilpiridinas utiles como inhibidores de cox-2'.
ES8404353A1 (es) Procedimiento para preparar derivados de piridazinona.
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES8306751A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES8707239A1 (es) Procedimiento para preparar nuevos derivados imidazo.
ES8702343A1 (es) Un procedimiento para la produccion de un derivado de diami-das de n-acilaminoacidos
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES8201583A1 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES8401034A1 (es) Derivados de quinolina.
ES8504127A1 (es) Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
ES8609323A1 (es) Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas.
ES8405000A1 (es) Un procedimiento para la preparacion de un derivado de carbostirilo.
ES8202000A1 (es) Procedimiento para preparar pirimidil-quinazolinas
ES8604162A1 (es) Procedimiento para preparar nuevos bencimidazoles
ES8708139A1 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas.